Lupin’s First Regional Reference Laboratory in Tamil Nadu
Plans to open over 300 collection centers in South India and 50 collection centers in the State by FY25
Chennai , 2023: Global pharma major Lupin Limited (Lupin) today announced the launch of its new
state-of-the-art Regional Reference Laboratory in Chennai, Tamil Nadu. This expansion marks a
pivotal moment in Lupin Diagnostics’ commitment to provide accessible, affordable, and quality
diagnostic healthcare services in South India. The newly launched laboratory enhances Lupin
Diagnostics’ extensive network which now comprises of 36 laboratories and over 600 collection
centers across India.
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic
technologies and a team of highly qualified clinical experts. Lupin Diagnostics offers an extensive
range of reliable and high-quality diagnostic services, including molecular diagnostics, cytogenetics,
flow cytometry, cytology, microbiology, serology, haematology, immunology, routine biochemistry,
and more, apart from routine and specialized tests.
In today’s healthcare landscape, evidence-based treatment has become the norm, with diagnostic
tests serving as the foundation for nearly 70% of treatment decisions. Lupin Diagnostics prioritizes
accuracy and quality by following stringent quality control protocols. Temperature-controlled
sample movement ensures the consistent integrity and quality of each sample. With a robust home
collection service team and network, Lupin Diagnostics prioritizes patient convenience, allowing
real-time tracking of assigned phlebotomists. Additionally, the Company enhances its value-added
services with dynamic smart reports, health monitoring tips, and historical trend graphs for
patients.
Commenting on the launch, Ravindra Kumar, CEO, Lupin Diagnostics said, “The launch of our
state-of-the-art Regional Reference Laboratory in Chennai signifies a significant step toward
accessible and reliable healthcare. Our vision extends beyond lab tests; it encompasses a
commitment to empowering doctors and patients through precise, evidence-based diagnostics.
With cutting-edge technology and a team of dedicated experts, we aim to redefine healthcare
experiences, fostering a society where accurate diagnosis is a cornerstone of well-being. This
expansion reflects our relentless dedication towards patient-centricity and purpose of being a
catalyst for healthier lives.”
Lupin Diagnostics’ unwavering commitment to quality and trust is underscored by the NABL
accreditations it has achieved. Within two years of operations, 30% of its laboratories (10
laboratories) have attained NABL accreditation.